Annji Pharmaceutical Co (ROCO:7754) Gross-Profit-to-Asset % : -0.10% (As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is Annji Pharmaceutical Co Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Annji Pharmaceutical Co's annualized Gross Profit for the quarter that ended in Dec. 2024 was NT$-1.03 Mil. Annji Pharmaceutical Co's average Total Assets over the quarter that ended in Dec. 2024 was NT$1,064.16 Mil. Therefore, Annji Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was -0.10%.

Annji Pharmaceutical Co Gross-Profit-to-Asset % Historical Data

The historical data trend for Annji Pharmaceutical Co's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Annji Pharmaceutical Co Gross-Profit-to-Asset % Chart

Annji Pharmaceutical Co Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Gross-Profit-to-Asset %

0.15

0.18

2.11

0.80

Annji Pharmaceutical Co Semi-Annual Data
	Dec21	Dec22	Jun23	Dec23	Jun24	Dec24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial			-	2.36	2.00	1.61	-0.10

Competitive Comparison of Annji Pharmaceutical Co's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Annji Pharmaceutical Co's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Annji Pharmaceutical Co's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Annji Pharmaceutical Co's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Annji Pharmaceutical Co's Gross-Profit-to-Asset % falls into.

Save Embed

;

Save Embed

;

Annji Pharmaceutical Co Gross-Profit-to-Asset % Calculation

Annji Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2024 )	/	( (Total Assets (A: Dec. 2023 )	+	Total Assets (A: Dec. 2024 ))	/ count )
	=	8.892	/	( (1207.983	+	1002.001)	/ 2 )
	=	8.892	/	1104.992
	=	0.80 %

Annji Pharmaceutical Co's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2024 )	/	( (Total Assets (Q: Jun. 2024 )	+	Total Assets (Q: Dec. 2024 ))	/ count )
	=	-1.026	/	( (1126.309	+	1002.001)	/ 2 )
	=	-1.026	/	1064.155
	=	-0.10 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Annji Pharmaceutical Co Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Annji Pharmaceutical Co's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Annji Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Annji Pharmaceutical Co Ltd (ROCO:7754) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zhongxiao E. Raod, 16th Floor-6, No. 508, Sector 7, Nangang Distrist, Taipei, TWN, 115011

Website

https://www.ajpharm.com

Annji Pharmaceutical Co Ltd is an R&D based, clinical-stage new drug company dedicated to the development of first-in-class small molecules focusing on indications with highly unmet needs in the therapeutic areas of neurology, dermatology, and inflammatory disorders, including rare diseases such as idiopathic pulmonary fibrosis and Kennedy's disease, or SBMA (Spinal and bulbar muscular atrophy). Its pipeline products include AJ201, AJ302 and AJ303.

Annji Pharmaceutical Co Headlines

No Headlines